Delivery Order SPE2DB22D2206-SPE2DB25FDU73

Award Date 10/16/24
Potential Completion Date 11/6/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,482.87 firm fixed price delivery order is for the supply of TALVEY 3 MG/1.5 ML VIAL 1.5ML pharmaceutical products. This award is part of Amerisourcebergen's broader support of DLA Troop Support Medical programs, providing a range of pharmaceuticals, medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $6,715.01 Delivery Order contract is for the supply of TALVEY 40 MG/ML VIALML, a specific pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "TALVEY 40 MG/ML VIALML" medical products, with a ceiling value of $20,944.77 and a completion date of February 19, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564801707 TALVEY 40 MG/ML VIALML to the Defense Logistics Agency (DLA). The $20,145.03 Firm Fixed Price delivery order contract has a ceiling value of $20,145.03 and an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This federal contract award, valued at $1,526.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TDVAX VIAL 0.5ML medical supplies, with an ultimate completion date of September 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,323.84, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,628.10 firm fixed-price delivery order is for the supply of TDVAX VIAL 0.5ML medical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.87 firm fixed-price delivery order contract is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FADJ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,985.43 fixed-price delivery order is for the supply of TIVDAK 40 MG VIALS. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,283.74 firm fixed-price delivery order is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDU73
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.07 firm fixed-price delivery order is for the supply of 4566120553 TALVEY 3 MG/1.5 ML VIAL 1.5ML, with a completion date of November 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/15/25, 9:23 AM